Ann Aerts Selected Research

Leprosy (Hansen's Disease)

12/2021	Preventing leprosy with retrospective active case finding combined with single-dose rifampicin for contacts in a low endemic setting: results of the Leprosy Post-Exposure Prophylaxis program in Cambodia.
1/2021	Leprosy post-exposure prophylaxis with single-dose rifampicin (LPEP): an international feasibility programme.
1/2021	The long-term impact of the Leprosy Post-Exposure Prophylaxis (LPEP) program on leprosy incidence: A modelling study.
4/2018	The Leprosy Post-Exposure Prophylaxis (LPEP) programme: update and interim analysis.
1/2017	Multidrug therapy for leprosy: a game changer on the path to elimination.
11/2016	Leprosy Post-Exposure Prophylaxis (LPEP) programme: study protocol for evaluating the feasibility and impact on case detection rates of contact tracing and single dose rifampicin.
3/2014	Role of contact tracing and prevention strategies in the interruption of leprosy transmission.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ann Aerts Research Topics

Disease

7	Leprosy (Hansen's Disease) 12/2021 - 03/2014
5	Hypertension (High Blood Pressure) 10/2021 - 01/2011
1	Malaria 01/2018
1	Infections 03/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2011

Drug/Important Bio-Agent (IBA)

7	Rifampin (Rifampicin)FDA LinkGeneric 12/2021 - 03/2014
2	Antihypertensive Agents (Antihypertensives)IBA 10/2021 - 01/2017
2	Valsartan (Vals)FDA Link 01/2017 - 01/2011
1	Clofazimine (Lamprene)FDA Link 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2017
1	Dapsone FDA Link 01/2017
1	UK 1IBA 01/2016
1	Valsartan Drug Combination Amlodipine FDA Link 06/2011

Therapy/Procedure

2	Therapeutics 01/2017 - 03/2014
1	Mass Drug Administration 01/2018
1	Chemoprevention 03/2014